Hostname: page-component-7b7567c8c-wxvwp Total loading time: 0 Render date: 2026-11-16T19:00:55.918Z Has data issue: false hasContentIssue false

Epidemiology, length of stay, and survival outcomes of Candida auris infections in a tertiary care center in the greater detroit area

Published online by Cambridge University Press:  27 November 2025

Hussein Tehaili*
Affiliation:
School of Medicine, Division of Infectious Diseases, Wayne State University, Detroit, MI, USA
Shayan Sharifi
Affiliation:
Department of Industrial and Systems Engineering, Wayne State University, Detroit, MI, USA
Sruti Ramamoorthy
Affiliation:
School of Medicine, Wayne State University, Detroit, MI, USA
Melike Yildirim
Affiliation:
Department of Industrial and Systems Engineering, Wayne State University, Detroit, MI, USAFamily Medicine and Public Health Sciences, Wayne State University, Detroit, MI, USA
Prabhnoor Dhillon
Affiliation:
Family Medicine and Public Health Sciences, Wayne State University, Detroit, MI, USAAdult Central Campus Infection Control and Epidemiology Department, Detroit Medical Center, Detroit, MI, USA
Raveen Mahngar
Affiliation:
Adult Central Campus Infection Control and Epidemiology Department, Detroit Medical Center, Detroit, MI, USA
Lavina Jabbo
Affiliation:
Adult Central Campus Infection Control and Epidemiology Department, Detroit Medical Center, Detroit, MI, USA
Marco R. Scipione
Affiliation:
Detroit Receiving Hospital, Detroit, MI, USA
Hossein Salimnia
Affiliation:
Detroit Medical Center, Microbiology Division, Detroit, MI, USASchool of Medicine, Department of Pathology, Wayne State University, Detroit, MI, USA
Glenn Tillotson
Affiliation:
GST Micro North, VA, USA
Teena Chopra
Affiliation:
School of Medicine, Division of Infectious Diseases, Wayne State University, Detroit, MI, USAAdult Central Campus Infection Control and Epidemiology Department, Detroit Medical Center, Detroit, MI, USA
*
Corresponding author: Hussein Tehaili; Email: drtehaili@gmail.com

Abstract

Objectives:

To investigate the epidemiology and clinical outcomes of Candida auris (C. auris), reclassified Candidozyma auris, in a Detroit tertiary care center, focusing on mortality, length of stay (LOS), glucose variability, and demographic factors.

Setting:

Inpatient admissions in a Detroit tertiary care center, June 2023–March 2025.

Patients:

Among 9,025 C. auris tests, 725 (8.03%) were positive. A subpopulation of 242 hospitalized patients was analyzed for outcomes.

Methods:

Clinical and demographic data, including infection status, mortality, and LOS, were analyzed. Glucose variability was assessed by the coefficient of variation. ANOVA and Kruskal–Wallis tests evaluated group differences, pairwise Z-tests compared mortality, and a competing-risks survival analysis estimated probabilities of discharge and in-hospital death.

Results:

Mortality was highest among colonized/infected patients (31.3%) and significantly associated with race (p = 0.0072) and ethnicity (p = 0.0069). High glucose variability (>190 mg/dL) was linked to increased mortality (27.63%) and prolonged LOS (46.14 days; p < 0.01). Infected patients had the longest LOS (67.9 days), followed by colonized/infected (39.9) and colonized-only (30.2; p < 0.001).

Conclusion:

C. auris disproportionately affects African American patients and those with high glucose variability, contributing to higher mortality and longer hospitalization. Infection status and glycemic instability were the strongest predictors of LOS, while racial and ethnic disparities influenced mortality. Strengthened infection control, early identification, and optimized glucose management may improve outcomes in high-risk populations.

Information

Type
Original Article
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2025. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America
Figure 0

Table 1.Summary of mortality rates across demographic and clinical categories of subpopulations (June 2023 – February 2024)

Figure 1

Figure 1.Cumulative incidence of in-hospital death, discharge alive, and probability of remaining hospitalized by length of stay (LOS), June 2023–February 2024. Curves were estimated using a competing-risks survival framework with the Aalen–Johansen estimator. Shaded regions indicate 95 % confidence intervals.

Figure 2

Table 2.Summary of length of stay (LOS) across demographic and clinical categories of subpopulations (June 2023 -February 2024)

Supplementary material: File

Tehaili et al. supplementary material

Tehaili et al. supplementary material
Download Tehaili et al. supplementary material(File)
File 615.6 KB